Slepian to head MicroMed's scientific advisory board
This article was originally published in Clinica
MicroMed Cardiovascular, the developer of the HeartAssist 5 left ventricular assist device (LVAD), has appointed Marvin Slepian as chairman of its scientific advisory board. Dr Slepian is the co-founder, chief medical and scientific officer and chairman of SynCardia Systems, the manufacturer of the world's first and only approved total artificial heart. Other members of MicroMed's scientific advisory board include Drs George Noon, coinventor of the HeartAssist 5, and Matthias Loebe, Professor at Baylor College of Medicine. The HeartAssist 5, also known as the Modern DeBakey VAD, is CE marked for both adult and paediatric use – in the US, it is approved only for paediatric use. The light-weight, miniature pump is one of the few devices of its kind that can be implanted above the diaphragm, adjacent to the heart. Unlike other LVADs, the HeartAssist 5 is said to be the only one that can offer precise, direct flow measurement.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.